Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

Borja Ibáñez, Stefan James, Stefan Agewall et al. · European Heart Journal · 2017 · 9.8K citations · Full text

Medicine, Cardiology, Internal Medicine +16

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Ezra A. Amsterdam, Nanette K. Wenger, Ralph G. Brindis et al. · Journal of the American College of Cardiology · 2014 · 3.6K citations

Medicine, Cardiology, Internal Medicine +12

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

Marco Valgimigli, Héctor Bueno, Robert A. Byrne et al. · European Heart Journal · 2017 · 3K citations · Full text

Medicine, Cardiology, Pharmacotherapy +14

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

Glenn N. Levine, Eric Bates, John A. Bittl et al. · Journal of the American College of Cardiology · 2016 · 1.6K citations

Medicine, Cardiology, Internal Medicine +16

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full <i>in vitro</i> analysis

Timothy D. Warner, Francesco Giuliano, Ivana Vojnovic et al. · Proceedings of the National Academy of Sciences · 1999 · 1.5K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12